OS Therapies (OSTX) Q1 2024 Earnings
OSTX·Reported May 20, 2024·Before market open
OS Therapies reported Q1 2024 revenue of $132.0K. Diluted EPS came in at $-0.07.
Revenue
$132.0K
Diluted EPS
$-0.07
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about OS Therapies's Q1 2024 earnings report.
OS Therapies (OSTX) reported Q1 2024 earnings on May 20, 2024 before market open.
OS Therapies reported revenue of $132.0K and diluted EPS of $-0.07 for Q1 2024.
You can read the 10-Q periodic report (0001213900-24-045141) directly on SEC EDGAR. The filing index links above go to sec.gov.